Colgate-Palmolive Company $CL Shares Purchased by Bath Savings Trust Co

Key Points

• Bath Savings Trust Co increased its holdings in Colgate-Palmolive Company by 15.3% in the 2nd quarter, owning a total of 80,294 shares worth approximately $7.3 million.
• Analysts have varied opinions on the stock, with a consensus rating of Moderate Buy and an average price target of $98.00.
• Colgate-Palmolive recently reported an EPS of $0.92, exceeding expectations, with quarterly revenue up 1.0% year-over-year.

Bath Savings Trust Co increased its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 15.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,294 shares of the company's stock after acquiring an additional 10,626 shares during the period. Bath Savings Trust Co's holdings in Colgate-Palmolive were worth $7,299,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CL. Westend Capital Management LLC lifted its stake in Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock worth $28,000 after acquiring an additional 287 shares in the last quarter. Saudi Central Bank acquired a new position in Colgate-Palmolive during the 1st quarter worth about $29,000. Vermillion Wealth Management Inc. acquired a new position in Colgate-Palmolive during the 4th quarter worth about $31,000. Finally, Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Citigroup reduced their price target on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. Morgan Stanley reduced their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, Barclays increased their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $98.00.

Colgate-Palmolive Trading Up 0.8%

CL opened at $82.14 on Thursday. Colgate-Palmolive Company has a one year low of $81.41 and a one year high of $104.75. The company has a market cap of $66.39 billion, a P/E ratio of 23.07, a PEG ratio of 4.24 and a beta of 0.35. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The business's 50-day simple moving average is $85.32 and its 200-day simple moving average is $89.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The business's revenue for the quarter was up 1.0% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio is presently 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.